Noble Investment Group Acquires Renaissance Reno Downtown Hotel & Spa

NB Renaissance and Ardian to Acquire Majority Stake in Neopharmed Gentili

November 9, 2022

Pharmaceuticals

NB Renaissance won a beauty contest to partner with Ardian and acquire majority ownership of Italian pharmaceutical group Neopharmed Gentili via a 50/50 vehicle, valuing the company at about €1.4–1.5 billion. The Del Bono family (through Mediolanum Farmaceutici) will retain a minority stake while Ardian will sell its existing stake into the vehicle and reinvest alongside NB Renaissance to hold half of the vehicle.

NB Renaissance Acquires Arbo S.p.A.

April 25, 2022

Building Products

NB Renaissance, the Italian private equity arm of Neuberger Berman, has acquired a majority stake in Arbo S.p.A., an Italian distributor of heating-system spare parts, air-conditioning systems and plumbing products. The investment will support consolidation across Italy and accelerate Arbo's international growth; sellers included Bravo Capital and Narval Investimenti.

Dynamic City Capital Acquires The Wilde Resort and Spa

April 23, 2025

Restaurants & Hospitality

Dynamic City Capital, a Provo, Utah–based real estate investment firm, has acquired The Wilde Resort and Spa in Sedona, Arizona. The 137-room luxury spa resort expands DCC's portfolio into the lifestyle/destination hospitality segment and strengthens its presence in Arizona.

Trinity and Oaktree Acquire Hyatt Regency Indian Wells Resort & Spa

April 4, 2022

Restaurants & Hospitality

Funds managed by Trinity Real Estate Investments (Trinity) and Oaktree Capital Management acquired the 530-key Hyatt Regency Indian Wells Resort & Spa in Indian Wells, California. The joint venture plans a multi-million-dollar capital improvement program to reposition the resort while Hyatt continues to manage the property under a long-term management agreement.

Essential Pharma Acquires Renaissance Pharma Ltd

April 2, 2024

Pharmaceuticals

Essential Pharma has completed the acquisition of all issued share capital of Renaissance Pharma Ltd, gaining the clinical-stage immunotherapy Hu14.18K322A (Hu14.18) for treatment of high‑risk neuroblastoma. The deal adds a development‑stage rare disease oncology asset to Essential Pharma's portfolio; Renaissance's CEO Simon Ball and members of the Renaissance team will continue to work with Essential on further development in partnership with St. Jude Children's Research Hospital.

Evermore Partners and New Castle Hotels & Resorts Acquire Montana Marriott Portfolio

March 30, 2023

Real Estate

Denver-based Evermore Partners and Ridgefield-based New Castle Hotels & Resorts acquired the Montana Marriott Portfolio in downtown Missoula, Montana, comprising a 105-key AC Hotel by Marriott, a 175-key Residence Inn by Marriott, and The Mercantile (approx. 20,000 sq. ft. of retail). The co-sponsors said the acquisition expands their presence in the Rocky Mountain region and broadens New Castle's management platform to the West.